US Stock MarketDetailed Quotes

ALZN Alzamend Neuro

Watchlist
  • 1.1100
  • -0.1400-11.20%
Close Dec 20 16:00 ET
  • 1.1000
  • -0.0100-0.90%
Post 20:01 ET
6.03MMarket Cap-0.18P/E (TTM)

About Alzamend Neuro Company

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.

Company Profile

SymbolALZN
Company NameAlzamend Neuro
Listing DateJun 15, 2021
Issue Price5.00
Founded2016
CEOMr. Stephan Jackman
MarketNASDAQ
Employees7
Fiscal Year Ends04-30
Address3480 Peachtree Road NE,Suite 103,2nd Floor
CityAtlanta
ProvinceGeorgia
CountryUnited States of America
Zip Code30326
Phone1-844-722-6333

Company Executives

  • Name
  • Position
  • Salary
  • Stephan Jackman
  • Chief Executive Officer and Director
  • 2.22M
  • David J. Katzoff
  • Chief Financial Officer and Principal Accounting Officer
  • 116.67K
  • Kenneth S. Cragun
  • Senior Vice President, Finance
  • --
  • Henry C.W. Nisser
  • Executive Vice President, General Counsel and Director
  • --
  • Milton C. Ault,III
  • Vice Chairman of the Board
  • --
  • William B. Horne
  • Chairman of the Board
  • 50.00K
  • Jeffrey Oram
  • Independent Director
  • 25.00K
  • Dr. Lynne Fahey McGrath, M.P.H.,PhD,Q.C.
  • Independent Director
  • 25.00K
  • Dr. Andrew H. Woo, M.D.,PhD
  • Independent Director
  • 25.00K
  • Mark Garland Gustafson
  • Independent Director
  • 25.00K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.